Mantle cell lymphoma echocardiography and ultrasound: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
Line 20: | Line 20: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Revision as of 02:31, 27 November 2017
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma echocardiography and ultrasound On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma echocardiography and ultrasound |
Mantle cell lymphoma echocardiography and ultrasound in the news |
Blogs on Mantle cell lymphoma echocardiography and ultrasound |
Risk calculators and risk factors for Mantle cell lymphoma echocardiography and ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
On ultrasound, mantle cell lymphoma is characterized by hepatomegaly and splenomegaly.
Ultrasound
On ultrasound, mantle cell lymphoma is characterized by: